Boston Advisors LLC decreased its stake in LHC Group Inc. (NASDAQ:LHCG) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,999 shares of the company’s stock after selling 255 shares during the period. Boston Advisors LLC’s holdings in LHC Group were worth $5,583,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of LHC Group during the fourth quarter valued at approximately $11,656,000. TIAA CREF Investment Management LLC increased its position in shares of LHC Group by 10.9% in the first quarter. TIAA CREF Investment Management LLC now owns 124,879 shares of the company’s stock valued at $4,441,000 after buying an additional 12,273 shares during the last quarter. Algert Global LLC increased its position in shares of LHC Group by 30.1% in the first quarter. Algert Global LLC now owns 9,942 shares of the company’s stock valued at $354,000 after buying an additional 2,302 shares during the last quarter. Acrospire Investment Management LLC acquired a new position in shares of LHC Group during the first quarter valued at about $100,000. Finally, Picton Mahoney Asset Management increased its position in shares of LHC Group by 21.7% in the first quarter. Picton Mahoney Asset Management now owns 2,800 shares of the company’s stock valued at $100,000 after buying an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 80.71% of the company’s stock.
Shares of LHC Group Inc. (NASDAQ:LHCG) traded up 0.58% during mid-day trading on Wednesday, hitting $38.10. 117,845 shares of the stock traded hands. The firm’s 50 day moving average price is $36.88 and its 200-day moving average price is $39.93. The stock has a market cap of $691.63 million, a P/E ratio of 19.95 and a beta of 0.78. LHC Group Inc. has a 12-month low of $32.77 and a 12-month high of $49.34.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.52 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.52. LHC Group had a net margin of 3.87% and a return on equity of 9.64%. The business had revenue of $226 million for the quarter, compared to analysts’ expectations of $221.09 million. During the same quarter last year, the company earned $0.51 EPS. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. Analysts predict that LHC Group Inc. will post $1.99 earnings per share for the current year.
Several research analysts have issued reports on the stock. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $46.00 price objective (down from $50.00) on shares of LHC Group in a research report on Tuesday, September 13th. Stephens assumed coverage on shares of LHC Group in a research report on Friday, June 17th. They set an “overweight” rating and a $55.00 price objective on the stock. Finally, Zacks Investment Research downgraded shares of LHC Group from a “buy” rating to a “sell” rating in a research report on Tuesday, August 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $47.71.
In related news, Director Kenneth E. Thorpe sold 1,450 shares of the stock in a transaction dated Monday, August 22nd. The shares were sold at an average price of $36.88, for a total value of $53,476.00. Following the sale, the director now owns 17,550 shares of the company’s stock, valued at approximately $647,244. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 18.30% of the stock is currently owned by corporate insiders.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.